Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
Link ID 3981
Title Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
Url http://www.medscape.com/viewarticle/571338?src=rss
Description VEGF inhibitors, such as bevacizumab, may cause glomerular disease that is characteristic of thrombotic microangiopathy. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 13, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. HPV-Positive Head and Neck Cancer Has Better Response to Treatment
  Tumors positive for human papillomavirus (HPV) have a better response to therapy, leading to significantly better survival than HPV-negative cancers. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Structure of Telomerase Deciphered, May Lead to Targeted Cancer Therapy
  Identification of the active region of telomerase, an enzyme that plays a major role in the development and progression of nearly all human malignancies, might eventually lead to new targeted therapies. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Breast Cancer Within 2 Years of Childbirth Linked to Poor Prognosis
  A study shows that women who have breast cancer within 2 years of their last pregnancy (or 2-4 years) after delivery are more likely to have a poor prognosis. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Current Perspectives on the Management of Chronic Myeloid Leukemia
  Review the molecular pathogenesis of chronic myeloid leukemia, and explore the latest advances in tyrosine kinase inhibitors for its treatment.
Category:   Articles > Hematology-Oncology


5. International Approvals: Nexavar, Elaprase, Aranesp
  Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); Japan has approved idursulfase solution (Elaprase). Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS